Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Reducing sedentary behavior in prostate cancer survivors

Official title: A Distance-based, Randomized Controlled Trial for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Run by University of Toronto · NCT05214937 · Data updated 2026-11-12

This study is testing if a special program with support and a FitBit can help prostate cancer survivors move more and sit less over 12 weeks.

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment120 (estimated)
SponsorUniversity of Toronto
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedFebruary 15, 2022
Main results expectedDecember 1, 2025
Study endsDecember 1, 2026
Registry record updatedDecember 4, 2024
Trial IDNCT05214937 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are prostate cancer survivors aged 18 and older who are not currently undergoing radiation or chemotherapy and report high levels of sedentary behavior.

Probably not a fit

Patients who are physically active or have medical conditions that prohibit walking may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial aims to evaluate a 12-week behavioral intervention designed to reduce sedentary behavior among prostate cancer survivors. Participants in the intervention group will receive a FitBit and six behavioral support sessions with a movement specialist, guided by the Multi-Process Action Control (M-PAC) framework. The control group will only receive a FitBit and access to public health resources. The study will assess the effectiveness of the intervention on sedentary behavior and physical activity levels immediately after the intervention and six months later.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of life and health outcomes for prostate cancer survivors by reducing sedentary behavior.

How similar studies have gone: While there is growing evidence supporting the reduction of sedentary behavior for health benefits in cancer survivors, this specific approach using the M-PAC framework is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \>= 18 years of age
* Diagnosed with localized or asymptomatic metastatic primary prostate cancer
* Not currently undergoing radiation or chemotherapy
* Proficient in English
* Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week)
* Self-report \>8 hours of daily sedentary behaviour
* In the contemplation or preparation stage for motivational readiness to change as determined by the Stages of Change Questionnaire
* Access to a smartphone, tablet, or computer
* No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis)
* Medical clearance from a primary health care provider (if necessary)
* Currently residing in Canada

Exclusion Criteria:

* Not planning to live in Canada for the next 12 months
* A medical condition that prohibits walking (e.g., severe knee or hip arthritis)
* Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)
* Have had a prior fall within the last 12-months
* Use a gait aid device

Where it's running

  • University of Toronto
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.